Table II.
Screening practices among the specialists evaluated with univariable logistic regression results
| Dermatologists (n=103) | Rheumatologists (n=94) | PCPs (n=102) | Total (n=299) | ORγ (95% CI) *D vs R; **D vs PCPs | |
|---|---|---|---|---|---|
| Smoking, n (%) | 81 (78.6 | 86 (91.5) | 56 (54.9) | 223 (74.6) | *OR 0.34 (0.14–0.81) **OR 3.02 (1.64–5.58) |
| Obesity, n (%) | 56 (54.4) | 47 (50.0) | 33 (32.4) | 136 (45.5) | *OR 1.19 (0.68–2.09) **OR 2.49 (1.41–4.40) |
| HTN, n (%) | 22 (21.4) | 34 (36.2) | 57 (55.9 | 113 (37.8) | *OR 0.48 (0.26–0.902) **OR 0.21 (0.12–0.40) |
| Dyslipidaemia, n (%) | 80 (77.7) | 92 (97.9) | 68 (66.7) | 240 (80.3) | *OR 0.08 (0.02–0.33) **OR 1.74 (0.94–3.23) |
| DM, n (%) | 77 (74.8) | 87 (92.6) | 74 (72.6) | 238 (79.6) | *OR 0.24 (0.01–0.58) **OR 1.12 (0.60–2.09) |
| Global screening, n (%) | 21 (20.6) | 29 (30.9) | 35 (34.3) | 85 (28.4) | *OR 0.57 (0.3–1.1) **OR 0.49 (0.26–0.92) |
| 10-year cardiovascular risk calculation, n (%) | 12 (11.7) | 12 (12.8) | 49 (48.0) | 73 (24.4) | *OR 0.90 (0.38–2.12) **OR 0.14 (0.07–0.29) |
D: dermatologists; 95% CI: 95% confidence interval; DM: diabetes mellitus; HTN: hypertension; OR: odds ratio; PCP: primary care physician; R: rheumatologists; γ: univariable logistic regression.